Humacyte Gets FDA's Full Approval for Universally Implantable Bioengineered Human Tissue; Shares Soar Premarket
Humacyte Gets FDA's Full Approval for Universally Implantable Bioengineered Human Tissue; Shares Soar Premarket
Humacyte獲得FDA的全面批准，用於普遍可植入的生物工程人類組織；股價在盤前大幅上漲
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間